Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1985 Oct;62:5–18. doi: 10.1289/ehp.85625

Chemical and biochemical dosimetry of exposure to genotoxic chemicals.

G N Wogan, N J Gorelick
PMCID: PMC1568678  PMID: 4085448

Abstract

Epidemiologic studies designed to evaluate the health significance of environmental chemicals are compromised by the lack of quantitative exposure data for individuals in exposed populations. Monitoring data on levels of compounds in environmental media often represent the only information available, and average population exposure is therefore the only quantitative parameter that can be calculated. Biological monitoring, i.e., measurements on cells, tissues or body fluids of exposed persons, has the objective of defining the so-called "internal dose" or "effective dose" on an individual basis. Such measurements can be used to ensure that current or past exposure does not entail unacceptable health risks, or can detect potentially excessive exposure before the appearance of adverse health effects. Results obtained through this approach can be interpreted on an individual basis and also used to estimate for that individual the amount of chemical absorbed during a specific time interval or the amount bound to critical sites. They may also be useful for characterization of community exposure by analyzing results obtained in groups of individuals within the general population. In this respect, biological monitoring data complement environmental measurements but have certain advantages in estimating health risks. Most importantly, the data obtained are more directly related to adverse effects and thus provide a better estimate of risk than ambient monitoring. Biological monitoring also takes into account absorption by all routes, integrates exposure from all sources, and therefore can be used as a basis for estimate of total risk from multiple chemicals.

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott P. J., Coombs M. M. DNA adducts of the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, in vivo and in vitro: high pressure liquid chromatographic separation and partial characterization. Carcinogenesis. 1981;2(7):629–636. doi: 10.1093/carcin/2.7.629. [DOI] [PubMed] [Google Scholar]
  2. Abbott P. J., Crew F. Repair of DNA adducts of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one in mouse tissues and its relation to tumor induction. Cancer Res. 1981 Oct;41(10):4115–4120. [PubMed] [Google Scholar]
  3. Abbott P. J. Strain-specific tumorigenesis in mouse skin induced by the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, and its relation to DNA adduct formation and persistence. Cancer Res. 1983 May;43(5):2261–2266. [PubMed] [Google Scholar]
  4. Al-Dabbagh S. G., Idle J. R., Smith R. L. Animal modelling of human polymorphic drug oxidation--the metabolism of debrisoquine and phenacetin in rat inbred strains. J Pharm Pharmacol. 1981 Mar;33(3):161–164. doi: 10.1111/j.2042-7158.1981.tb13740.x. [DOI] [PubMed] [Google Scholar]
  5. Alexandrov K., Becker M., Frayssinet C., Dubowska W., Guerry R. Persistence of benzo[alpha]pyrenediolepoxide DNA adduct in mouse skin. Cancer Lett. 1982 Sep;16(3):247–251. doi: 10.1016/0304-3835(82)90003-9. [DOI] [PubMed] [Google Scholar]
  6. Alexandrov K., Rojas M., Bourgeois Y., Chouroulinkov I. The persistence of benzo[a]pyrene diol-epoxide deoxyguanosine adduct in mouse skin and its disappearance in rat skin. Carcinogenesis. 1983 Dec;4(12):1655–1657. doi: 10.1093/carcin/4.12.1655. [DOI] [PubMed] [Google Scholar]
  7. Allaben W. T., Weis C. C., Fullerton N. F., Beland F. A. Formation and persistence of DNA adducts from the carcinogen N-hydroxy-2-acetylaminofluorene in rat mammary gland in vivo. Carcinogenesis. 1983 Aug;4(8):1067–1070. doi: 10.1093/carcin/4.8.1067. [DOI] [PubMed] [Google Scholar]
  8. Appleton B. S., Goetchius M. P., Campbell T. C. Linear dose-response curve for the hepatic macromolecular binding of aflatoxin B1 in rats at very low exposures. Cancer Res. 1982 Sep;42(9):3659–3662. [PubMed] [Google Scholar]
  9. Ashurst S. W., Cohen G. M. In vivo formation of benzo(alpha)pyrene diol epoxide-deoxyadenosine adducts in the skin of mice susceptible to benzo(alpha)pyrene-induced carcinogenesis. Int J Cancer. 1981 Mar 15;27(3):357–364. doi: 10.1002/ijc.2910270315. [DOI] [PubMed] [Google Scholar]
  10. Autrup H., Grafstrom R. C., Brugh M., Lechner J. F., Haugen A., Trump B. F., Harris C. C. Comparison of benzo(a)pyrene metabolism in bronchus, esophagus, colon, and duodenum from the same individual. Cancer Res. 1982 Mar;42(3):934–938. [PubMed] [Google Scholar]
  11. Autrup H., Harris C. C., Trump B. F., Jeffrey A. M. Metabolism of benzo(a)pyrene and identification of the major benzo(a)pyrene-DNA adducts in cultured human colon. Cancer Res. 1978 Nov;38(11 Pt 1):3689–3696. [PubMed] [Google Scholar]
  12. BROOKES P., LAWLEY P. D. EVIDENCE FOR THE BINDING OF POLYNUCLEAR AROMATIC HYDROCARBONS TO THE NUCLEIC ACIDS OF MOUSE SKIN: RELATION BETWEEN CARCINOGENIC POWER OF HYDROCARBONS AND THEIR BINDING TO DEOXYRIBONUCLEIC ACID. Nature. 1964 May 23;202:781–784. doi: 10.1038/202781a0. [DOI] [PubMed] [Google Scholar]
  13. Bailey E., Connors T. A., Farmer P. B., Gorf S. M., Rickard J. Methylation of cysteine in hemoglobin following exposure to methylating agents. Cancer Res. 1981 Jun;41(6):2514–2517. [PubMed] [Google Scholar]
  14. Becroft D. M., Webster D. R. Aflatoxins and Reye's disease. Br Med J. 1972 Oct 14;4(5832):117–117. doi: 10.1136/bmj.4.5832.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bedell M. A., Lewis J. G., Billings K. C., Swenberg J. A. Cell specificity in hepatocarcinogenesis: preferential accumulation of O6-methylguanine in target cell DNA during continuous exposure to rats to 1,2-dimethylhydrazine. Cancer Res. 1982 Aug;42(8):3079–3083. [PubMed] [Google Scholar]
  16. Beland F. A., Dooley K. L., Jackson C. D. Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2-acetylaminofluorene. Cancer Res. 1982 Apr;42(4):1348–1354. [PubMed] [Google Scholar]
  17. Borek C., Sachs L. The number of cell generations required to fix the transformed state in X-ray-induced transformation. Proc Natl Acad Sci U S A. 1968 Jan;59(1):83–85. doi: 10.1073/pnas.59.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Calleman C. J., Ehrenberg L., Jansson B., Osterman-Golkar S., Segerbäck D., Svensson K., Wachtmeister C. A. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide. J Environ Pathol Toxicol. 1978 Nov-Dec;2(2):427–442. [PubMed] [Google Scholar]
  19. Campbell T. C., Caedo J. P., Jr, Bulatao-Jayme J., Salamat L., Engel R. W. Aflatoxin M1 in human urine. Nature. 1970 Jul 25;227(5256):403–404. doi: 10.1038/227403a0. [DOI] [PubMed] [Google Scholar]
  20. Casanova-Schmitz M., Starr T. B., Heck H. D. Differentiation between metabolic incorporation and covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by inhaled [14C]- and [3H]formaldehyde. Toxicol Appl Pharmacol. 1984 Oct;76(1):26–44. doi: 10.1016/0041-008x(84)90026-7. [DOI] [PubMed] [Google Scholar]
  21. Cayama E., Tsuda H., Sarma D. S., Farber E. Initiation of chemical carcinogenesis requires cell proliferation. Nature. 1978 Sep 7;275(5675):60–62. doi: 10.1038/275060a0. [DOI] [PubMed] [Google Scholar]
  22. Cleaver J. E. Defective repair replication of DNA in xeroderma pigmentosum. Nature. 1968 May 18;218(5142):652–656. doi: 10.1038/218652a0. [DOI] [PubMed] [Google Scholar]
  23. Cohen G. M., Mehta R., Meredith-Brown M. Large interindividual variations in metabolism of benzo(alpha)pyrene by peripheral lung tissue from lung cancer patients. Int J Cancer. 1979 Aug;24(2):129–133. doi: 10.1002/ijc.2910240202. [DOI] [PubMed] [Google Scholar]
  24. Columbano A., Rajalakshmi S., Sarma D. S. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res. 1981 Jun;41(6):2079–2083. [PubMed] [Google Scholar]
  25. Croy R. G., Wogan G. N. Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys. J Natl Cancer Inst. 1981 Apr;66(4):761–768. [PubMed] [Google Scholar]
  26. Croy R. G., Wogan G. N. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res. 1981 Jan;41(1):197–203. [PubMed] [Google Scholar]
  27. Daniel F. B., Joyce N. J. 7,12-Dimethylbenz[a]anthracene--DNA adducts in Sprague-Dawley and Long-Evans female rats: the relationship of DNA adducts to mammary cancer. Carcinogenesis. 1984 Aug;5(8):1021–1026. doi: 10.1093/carcin/5.8.1021. [DOI] [PubMed] [Google Scholar]
  28. Daniel F. B., Schut H. A., Sandwisch D. W., Schenck K. M., Hoffmann C. O., Patrick J. R., Stoner G. D. Interspecies comparisons of benzo(a)pyrene metabolism and DNA-adduct formation in cultured human and animal bladder and tracheobronchial tissues. Cancer Res. 1983 Oct;43(10):4723–4729. [PubMed] [Google Scholar]
  29. Dipple A., Pigott M. A., Bigger C. A., Blake D. M. 7,12-dimethylbenz[a] anthracene--DNA binding in mouse skin: response of different mouse strains and effects of various modifiers of carcinogenesis. Carcinogenesis. 1984 Aug;5(8):1087–1090. doi: 10.1093/carcin/5.8.1087. [DOI] [PubMed] [Google Scholar]
  30. Dooley K. L., Beland F. A., Bucci T. J., Kadlubar F. F. Local carcinogenicity, rates of absorption, extent and persistence of macromolecular binding, and acute histopathological effects of N-hydroxy-1-naphthylamine and N-hydroxy-2-naphthylamine. Cancer Res. 1984 Mar;44(3):1172–1177. [PubMed] [Google Scholar]
  31. Dunn B. P. Wide-range linear dose-response curve for DNA binding of orally administered benzo(a)pyrene in mice. Cancer Res. 1983 Jun;43(6):2654–2658. [PubMed] [Google Scholar]
  32. Dvorackova I., Stora C., Ayraud N. Evidence of aflatoxin B1 in two cases of lung cancer in man. J Cancer Res Clin Oncol. 1981;100(2):221–224. doi: 10.1007/BF00403368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Eastman A., Bresnick E. Persistent binding of 3-methylcholanthrene to mouse lung DNA and its correlation with susceptibility to pulmonary neoplasia. Cancer Res. 1979 Jul;39(7 Pt 1):2400–2405. [PubMed] [Google Scholar]
  34. Ehrenberg L., Osterman-Golkar S. Alkylation of macromolecules for detecting mutagenic agents. Teratog Carcinog Mutagen. 1980;1(1):105–127. doi: 10.1002/tcm.1770010111. [DOI] [PubMed] [Google Scholar]
  35. Goth R., Rajewsky M. F. Persistence of O6-ethylguanine in rat-brain DNA: correlation with nervous system-specific carcinogenesis by ethylnitrosourea. Proc Natl Acad Sci U S A. 1974 Mar;71(3):639–643. doi: 10.1073/pnas.71.3.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Grafstrom R. C., Pegg A. E., Trump B. F., Harris C. C. O6-alkylguanine-DNA alkyltransferase activity in normal human tissues and cells. Cancer Res. 1984 Jul;44(7):2855–2857. [PubMed] [Google Scholar]
  37. Groopman J. D., Haugen A., Goodrich G. R., Wogan G. N., Harris C. C. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies. Cancer Res. 1982 Aug;42(8):3120–3124. [PubMed] [Google Scholar]
  38. Gupta R. C., Dighe N. R. Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofluorene, 4-acetylaminobiphenyl, and 2-acetylaminophenanthrene. Carcinogenesis. 1984 Mar;5(3):343–349. doi: 10.1093/carcin/5.3.343. [DOI] [PubMed] [Google Scholar]
  39. Gupta R. C., Reddy M. V., Randerath K. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts. Carcinogenesis. 1982;3(9):1081–1092. doi: 10.1093/carcin/3.9.1081. [DOI] [PubMed] [Google Scholar]
  40. Harris C. C., Autrup H., Connor R., Barrett L. A., McDowell E. M., Trump B. F. Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi. Science. 1976 Dec 3;194(4269):1067–1069. doi: 10.1126/science.982061. [DOI] [PubMed] [Google Scholar]
  41. Harris C. C., Autrup H., Stoner G. D., Trump B. F., Hillman E., Schafer P. W., Jeffrey A. M. Metabolism of benzo(a)pyrene, N-nitrosodimethylamine, and N-nitrosopyrrolidine and identification of the major carcinogen-DNA adducts formed in cultured human esophagus. Cancer Res. 1979 Nov;39(11):4401–4406. [PubMed] [Google Scholar]
  42. Harris C. C., Trump B. F., Grafstrom R., Autrup H. Differences in metabolism of chemical carcinogens in cultured human epithelial tissues and cells. J Cell Biochem. 1982;18(3):285–294. doi: 10.1002/jcb.1982.240180304. [DOI] [PubMed] [Google Scholar]
  43. Haseltine W. A., Franklin W., Lippke J. A. New methods for detection of low levels of DNA damage in human populations. Environ Health Perspect. 1983 Feb;48:29–41. doi: 10.1289/ehp.834829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hendrickse R. G., Coulter J. B., Lamplugh S. M., Macfarlane S. B., Williams T. E., Omer M. I., Suliman G. I. Aflatoxins and kwashiorkor: a study in Sudanese children. Br Med J (Clin Res Ed) 1982 Sep 25;285(6345):843–846. doi: 10.1136/bmj.285.6345.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hsu I. C., Poirier M. C., Yuspa S. H., Grunberger D., Weinstein I. B., Yolken R. H., Harris C. C. Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Cancer Res. 1981 Mar;41(3):1091–1095. [PubMed] [Google Scholar]
  46. Hsu I. C., Poirier M. C., Yuspa S. H., Yolken R. H., Harris C. C. Ultrasensitive enzymatic radioimmunoassay (USERIA) detects femtomoles of acetylaminofluorene-DNA adducts. Carcinogenesis. 1980 May;1(5):455–458. doi: 10.1093/carcin/1.5.455. [DOI] [PubMed] [Google Scholar]
  47. Johnson H. J., Jr, Cernosek S. F., Jr, Gutierrez-Cernosek R. M., Brown L. L. Development of a radioimmunoassay procedure for 4-acetamidobiphenyl, a metabolite of the chemical carcinogen 4-aminobiphenyl, in urine. J Anal Toxicol. 1980 Mar-Apr;4(2):86–90. doi: 10.1093/jat/4.2.86. [DOI] [PubMed] [Google Scholar]
  48. Kadlubar F. F., Anson J. F., Dooley K. L., Beland F. A. Formation of urothelial and hepatic DNA adducts from carcinogen 2-naphthylamine. Carcinogenesis. 1981;2(5):467–470. doi: 10.1093/carcin/2.5.467. [DOI] [PubMed] [Google Scholar]
  49. Kadlubar F. F., Beranek D. T., Weis C. C., Evans F. E., Cox R., Irving C. C. Characterization of the purine ring-opened 7-methylguanine and its persistence in rat bladder epithelial DNA after treatment with the carcinogen N-methylnitrosourea. Carcinogenesis. 1984 May;5(5):587–592. doi: 10.1093/carcin/5.5.587. [DOI] [PubMed] [Google Scholar]
  50. Kyrtopoulos S. A., Swann P. F. The use of radioimmunoassay to study the formation and disappearance of O6-methylguanine in mouse liver satellite and main-band DNA following dimethylnitrosamine administration. J Cancer Res Clin Oncol. 1980;98(2):127–138. doi: 10.1007/BF00405957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Lamplugh S. M. Comparison of three methods for the extraction of aflatoxins from human serum in combination with a high-performance liquid chromatographic assay. J Chromatogr. 1983 Apr 8;273(2):442–448. doi: 10.1016/s0378-4347(00)80968-8. [DOI] [PubMed] [Google Scholar]
  52. Leadon S. A., Hanawalt P. C. Monoclonal antibody to DNA containing thymine glycol. Mutat Res. 1983 Aug;112(4):191–200. doi: 10.1016/0167-8817(83)90006-8. [DOI] [PubMed] [Google Scholar]
  53. Leadon S. A., Tyrrell R. M., Cerutti P. A. Excision repair of aflatoxin B1-DNA adducts in human fibroblasts. Cancer Res. 1981 Dec;41(12 Pt 1):5125–5129. [PubMed] [Google Scholar]
  54. Leng M., Sage E., Fuchs R. P., Duane M. P. Antibodies to DNA modified by the carcinogen N-acetoxy-N-2-acetylaminofluorene. FEBS Lett. 1978 Aug 15;92(2):207–210. doi: 10.1016/0014-5793(78)80755-8. [DOI] [PubMed] [Google Scholar]
  55. Lewis J. G., Swenberg J. A. Effect of 1,2-dimethylhydrazine and diethylnitrosamine on cell replication and unscheduled DNA synthesis in target and nontarget cell populations in rat liver following chronic administration. Cancer Res. 1982 Jan;42(1):89–92. [PubMed] [Google Scholar]
  56. Lovelace C. E., Njapau H., Salter L. F., Bayley A. C. Screening method for the detection of aflatoxin and metabolites in human urine: aflatoxins B1, G1, M1, B2a, G2a, aflatoxicols I and II. J Chromatogr. 1982 Jan 8;227(1):256–261. doi: 10.1016/s0378-4347(00)80382-5. [DOI] [PubMed] [Google Scholar]
  57. Lutz W. K. In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat Res. 1979 Dec;65(4):289–356. doi: 10.1016/0165-1110(79)90006-x. [DOI] [PubMed] [Google Scholar]
  58. Lutz W. K., Viviant A., Schlatter C. Nonlinear dose-response relationship for the binding of the carcinogen benzo(a)pyrene to rat liver DNA in vivo. Cancer Res. 1978 Mar;38(3):575–578. [PubMed] [Google Scholar]
  59. Mahoney E. M., Ball J. C., Swenson D. H., Richmond D., Maher V. M., McCormick J. J. Cytotoxicity and mutagenicity of aflatoxin dichloride in normal and repair deficient diploid human fibroblasts. Chem Biol Interact. 1984 Jun;50(1):59–76. doi: 10.1016/0009-2797(84)90132-7. [DOI] [PubMed] [Google Scholar]
  60. Martin C. N., Beland F. A., Roth R. W., Kadlubar F. F. Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro. Cancer Res. 1982 Jul;42(7):2678–2686. [PubMed] [Google Scholar]
  61. Müller R., Rajewsky M. F. Antibodies specific for DNA components structurally modified by chemical carcinogens. J Cancer Res Clin Oncol. 1981;102(2):99–113. doi: 10.1007/BF00410662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Müller R., Rajewsky M. F. Immunological quantification by high-affinity antibodies of O6-ethyldeoxyguanosine in DNA exposed to N-ethyl-N-nitrosourea. Cancer Res. 1980 Mar;40(3):887–896. [PubMed] [Google Scholar]
  63. Nelson D. B., Kimbrough R., Landrigan P. S., Hayes A. W., Yang G. C., Benanides J. Aflatoxin and Reye's syndrome: a case control study. Pediatrics. 1980 Dec;66(6):865–869. [PubMed] [Google Scholar]
  64. Neumann H. G. Dose-response relationship in the primary lesion of strong electrophilic carcinogens. Arch Toxicol Suppl. 1980;3:69–77. doi: 10.1007/978-3-642-67389-4_6. [DOI] [PubMed] [Google Scholar]
  65. Onyemelukwe C. G., Nirodi C., West C. E. Aflatoxin B1 in hepatocellular carcinoma. Trop Geogr Med. 1980 Sep;32(3):237–240. [PubMed] [Google Scholar]
  66. Osterman-Golkar S., Ehrenberg L., Segerbäck D., Hällström I. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat Res. 1976 Jan;34(1):1–10. doi: 10.1016/0027-5107(76)90256-6. [DOI] [PubMed] [Google Scholar]
  67. Osterman-Golkar S., Farmer P. B., Segerbäck D., Bailey E., Calleman C. J., Svensson K., Ehrenberg L. Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin. Teratog Carcinog Mutagen. 1983;3(5):395–405. doi: 10.1002/1520-6866(1990)3:5<395::aid-tcm1770030502>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  68. Osterman-Golkar S., Hultmark D., Segerbäck D., Calleman C. J., Göthe R., Ehrenberg L., Wachtmeister C. A. Alkylation of DNA and proteins in mice exposed to vinyl chloride. Biochem Biophys Res Commun. 1976 May 23;76(2):259–266. doi: 10.1016/0006-291x(77)90720-3. [DOI] [PubMed] [Google Scholar]
  69. Paterson M. C., Smith B. P., Lohman P. H., Anderson A. K., Fishman L. Defective excision repair of gamma-ray-damaged DNA in human (ataxia telangiectasia) fibroblasts. Nature. 1976 Apr 1;260(5550):444–447. doi: 10.1038/260444a0. [DOI] [PubMed] [Google Scholar]
  70. Pegg A. E., Perry W. Alkylation of nucleic acids and metabolism of small doses of dimethylnitrosamine in the rat. Cancer Res. 1981 Aug;41(8):3128–3132. [PubMed] [Google Scholar]
  71. Pelling J. C., Slaga T. J. Comparison of levels of benzo[a]pyrene diol epoxide diastereomers covalently bound in vivo to macromolecular components of the whole epidermis versus the basal cell layer. Carcinogenesis. 1982;3(10):1135–1141. doi: 10.1093/carcin/3.10.1135. [DOI] [PubMed] [Google Scholar]
  72. Pelling J. C., Slaga T. J., DiGiovanni J. Formation and persistence of DNA, RNA, and protein adducts in mouse skin exposed to pure optical enantiomers of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyre ne in vivo. Cancer Res. 1984 Mar;44(3):1081–1086. [PubMed] [Google Scholar]
  73. Pereira M. A., Chang L. W. Binding of chemical carcinogens and mutagens to rat hemoglobin. Chem Biol Interact. 1981 Jan;33(2-3):301–305. doi: 10.1016/0009-2797(81)90048-x. [DOI] [PubMed] [Google Scholar]
  74. Pereira M. A., Chang L. W. Binding of chloroform to mouse and rat hemoglobin. Chem Biol Interact. 1982 Mar 1;39(1):89–99. doi: 10.1016/0009-2797(82)90008-4. [DOI] [PubMed] [Google Scholar]
  75. Pereira M. A., Lin L. H., Chang L. W. Dose-dependency of 2-acetylaminofluorene binding to liver DNA and hemoglobin in mice and rats. Toxicol Appl Pharmacol. 1981 Sep 30;60(3):472–478. doi: 10.1016/0041-008x(81)90333-1. [DOI] [PubMed] [Google Scholar]
  76. Perera F. P., Poirier M. C., Yuspa S. H., Nakayama J., Jaretzki A., Curnen M. M., Knowles D. M., Weinstein I. B. A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays. Carcinogenesis. 1982;3(12):1405–1410. doi: 10.1093/carcin/3.12.1405. [DOI] [PubMed] [Google Scholar]
  77. Phillips D. H., Grover P. L., Sims P. The covalent binding of polycyclic hydrocarbons to DNA in the skin of mice of different strains. Int J Cancer. 1978 Oct 15;22(4):487–494. doi: 10.1002/ijc.2910220419. [DOI] [PubMed] [Google Scholar]
  78. Poirier M. C. Antibodies to carcinogen-DNA adducts. J Natl Cancer Inst. 1981 Sep;67(3):515–519. [PubMed] [Google Scholar]
  79. Poirier M. C., Lippard S. J., Zwelling L. A., Ushay H. M., Kerrigan D., Thill C. C., Santella R. M., Grunberger D., Yuspa S. H. Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6443–6447. doi: 10.1073/pnas.79.21.6443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Poirier M. C., Santella R., Weinstein I. B., Grunberger D., Yuspa S. H. Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res. 1980 Feb;40(2):412–416. [PubMed] [Google Scholar]
  81. Poirier M. C., Yuspa S. H., Weinstein I. B., Blobstein S. Detection of carcinogen-DNA adducts by radiommunoassay. Nature. 1977 Nov 10;270(5633):186–188. doi: 10.1038/270186a0. [DOI] [PubMed] [Google Scholar]
  82. Rahn R. O., Chang S. S., Holland J. M., Shugart L. R. A fluorometric-HPLC assay for quantitating the binding of benzo[a]pyrene metabolites to DNA. Biochem Biophys Res Commun. 1982 Nov 16;109(1):262–268. doi: 10.1016/0006-291x(82)91594-7. [DOI] [PubMed] [Google Scholar]
  83. Randerath E., Agrawal H. P., Reddy M. V., Randerath K. Highly persistent polycyclic aromatic hydrocarbon-DNA adducts in mouse skin: detection by 32P-postlabeling analysis. Cancer Lett. 1983 Aug;20(1):109–114. doi: 10.1016/0304-3835(83)90195-7. [DOI] [PubMed] [Google Scholar]
  84. Randerath K., Reddy M. V., Gupta R. C. 32P-labeling test for DNA damage. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6126–6129. doi: 10.1073/pnas.78.10.6126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Reddy M. V., Gupta R. C., Randerath E., Randerath K. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis. 1984 Feb;5(2):231–243. doi: 10.1093/carcin/5.2.231. [DOI] [PubMed] [Google Scholar]
  86. Rogan W. J., Gladen B. C., McKinney J. D., Albro P. W. Chromatographic evidence of polychlorinated biphenyl exposure from a spill. JAMA. 1983 Feb 25;249(8):1057–1059. [PubMed] [Google Scholar]
  87. Rogan W., Gladen B. Monitoring breast milk contamination to detect hazards from waste disposal. Environ Health Perspect. 1983 Feb;48:87–91. doi: 10.1289/ehp.834887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Ryan N. J., Hogan G. R., Hayes A. W., Unger P. D., Siraj M. Y. Aflatoxin B1; its role in the etiology of Reye's syndrome. Pediatrics. 1979 Jul;64(1):71–75. [PubMed] [Google Scholar]
  89. Saffhill R., Strickland P. T., Boyle J. M. Sensitive radioimmunoassays for O6-n-butyldeoxyguanosine, O2-n-butylthymidine and O4-n-butylthymidine. Carcinogenesis. 1982;3(5):547–552. doi: 10.1093/carcin/3.5.547. [DOI] [PubMed] [Google Scholar]
  90. Sage E., Fuchs R. P., Leng M. Reactivity of the antibodies to DNA modified by the carcinogen N-acetoxy-N-acetyl-2-aminofluorene. Biochemistry. 1979 Apr 3;18(7):1328–1332. doi: 10.1021/bi00574a032. [DOI] [PubMed] [Google Scholar]
  91. Santella R. M., Lin C. D., Cleveland W. L., Weinstein I. B. Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide. Carcinogenesis. 1984 Mar;5(3):373–377. doi: 10.1093/carcin/5.3.373. [DOI] [PubMed] [Google Scholar]
  92. Savage E. P., Keefe T. J., Tessari J. D., Wheeler H. W., Applehans F. M., Goes E. A., Ford S. A. National study of chlorinated hydrocarbon insecticide residues in human milk, USA. I. Geographic distribution of dieldrin, heptachlor, heptachlor epoxide, chlordane, oxychlordane, and mirex. Am J Epidemiol. 1981 Apr;113(4):413–422. doi: 10.1093/oxfordjournals.aje.a113109. [DOI] [PubMed] [Google Scholar]
  93. Segerbäck D. Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide. Chem Biol Interact. 1983 Jul 15;45(2):139–151. doi: 10.1016/0009-2797(83)90064-9. [DOI] [PubMed] [Google Scholar]
  94. Segerbäck D., Calleman C. J., Ehrenberg L., Löfroth G., Osterman-Golkar S. Evaluation of genetic risks of alkylating agents IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after-treatment of mice with methyl methanesulfonate. Mutat Res. 1978 Jan;49(1):71–82. doi: 10.1016/0027-5107(78)90079-9. [DOI] [PubMed] [Google Scholar]
  95. Shank R. C., Bourgeois C. H., Keschamras N., Chandavimol P. Aflatoxins in autopsy specimens from Thai children with an acute disease of unknown aetiology. Food Cosmet Toxicol. 1971 Aug;9(4):501–507. doi: 10.1016/0015-6264(71)90080-0. [DOI] [PubMed] [Google Scholar]
  96. Siraj M. Y., Hayes A. W., Unger P. D., Hogan G. R., Ryan N. J., Wray B. B. Analysis of aflatoxin B1 in human tissues with high-pressure liquid chromatography. Toxicol Appl Pharmacol. 1981 May;58(3):422–430. doi: 10.1016/0041-008x(81)90094-6. [DOI] [PubMed] [Google Scholar]
  97. Sizaret P., Malaveille C., Montesano R., Frayssinet C. Detection of aflatoxins and related metabolites by radioimmunoassay. J Natl Cancer Inst. 1982 Dec;69(6):1375–1381. [PubMed] [Google Scholar]
  98. Stowers S. J., Anderson M. W. Formation and persistence of benzo(a)pyrene metabolite-DNA adducts. Environ Health Perspect. 1985 Oct;62:31–39. doi: 10.1289/ehp.856231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Strickland P. T., Boyle J. M. Characterisation of two monoclonal antibodies specific for dimerised and non-dimerised adjacent thymidines in single stranded DNA. Photochem Photobiol. 1981 Nov;34(5):595–601. [PubMed] [Google Scholar]
  100. Swanstrom R., Shank P. R. X-Ray Intensifying Screens Greatly Enhance the Detection by Autoradiography of the Radioactive Isotopes 32P and 125I. Anal Biochem. 1978 May;86(1):184–192. doi: 10.1016/0003-2697(78)90333-0. [DOI] [PubMed] [Google Scholar]
  101. Swenberg J. A., Dyroff M. C., Bedell M. A., Popp J. A., Huh N., Kirstein U., Rajewsky M. F. O4-ethyldeoxythymidine, but not O6-ethyldeoxyguanosine, accumulates in hepatocyte DNA of rats exposed continuously to diethylnitrosamine. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1692–1695. doi: 10.1073/pnas.81.6.1692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Swift M., Sholman L., Perry M., Chase C. Malignant neoplasms in the families of patients with ataxia-telangiectasia. Cancer Res. 1976 Jan;36(1):209–215. [PubMed] [Google Scholar]
  103. Vahakangas K., Trivers G., Rowe M., Harris C. C. Benzo(a)pyrene diolepoxide-DNA adducts detected by synchronous fluorescence spectrophotometry. Environ Health Perspect. 1985 Oct;62:101–104. doi: 10.1289/ehp.8562101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Wigley C. B., Newbold R. F., Amos J., Brookes P. Cell-mediated mutagenesis in cultured Chinese hamster cells by polycyclic hydrocarbons: mutagenicity and DNA reaction related to carcinogenicity in a series of compounds. Int J Cancer. 1979 May 15;23(5):691–696. doi: 10.1002/ijc.2910230516. [DOI] [PubMed] [Google Scholar]
  105. Wild C. P., Smart G., Saffhill R., Boyle J. M. Radioimmunoassay of O6-methyldeoxyguanosine in DNA of cells alkylated in vitro and in vivo. Carcinogenesis. 1983 Dec;4(12):1605–1609. doi: 10.1093/carcin/4.12.1605. [DOI] [PubMed] [Google Scholar]
  106. Yang L. L., Maher V. M., McCormick J. J. Relationship between excision repair and the cytotoxic and mutagenic effect of the 'anti' 7,8-diol-9,10-epoxide of benzo[a]pyrene in human cells. Mutat Res. 1982 Jun;94(2):435–447. doi: 10.1016/0027-5107(82)90306-2. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES